JP2022519375A5
(cg-RX-API-DMAC7.html )
2023-02-17
JP2024526145A5
(cg-RX-API-DMAC7.html )
2025-06-20
JP6141958B2
(ja )
2017-06-07
増殖性疾患の治療のための併用療法(ベムラフェニブ及びmdm2阻害剤)
JP2022519385A5
(cg-RX-API-DMAC7.html )
2023-02-20
JP2022517433A5
(cg-RX-API-DMAC7.html )
2022-09-22
JP2019516733A5
(cg-RX-API-DMAC7.html )
2020-07-02
JP2018534311A5
(cg-RX-API-DMAC7.html )
2019-12-26
JP2016523858A
(ja )
2016-08-12
がんを治療するためのbtk阻害剤とフルオロウラシルとの併用
JP2012522837A5
(cg-RX-API-DMAC7.html )
2013-04-11
JP2021534094A5
(cg-RX-API-DMAC7.html )
2022-08-12
JP2015517523A5
(cg-RX-API-DMAC7.html )
2016-06-02
MX2024006270A
(es )
2024-06-11
Nueva composicion farmaceutica oral y regimen de dosificacion para la terapia de enfermedades pulmonares intersticiales fibrosantes progresivas.
MX2024010637A
(es )
2024-09-06
Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas.
CN104039148A
(zh )
2014-09-10
组合als疗法
JP2023524789A5
(cg-RX-API-DMAC7.html )
2024-05-16
Punt
1998
New drugs in the treatment of colorectal carcinoma
TW201625243A
(zh )
2016-07-16
用於治療黑素瘤之藥物組合
JP2016505050A5
(cg-RX-API-DMAC7.html )
2017-02-23
TW202327579A
(zh )
2023-07-16
Tead抑制劑的給藥方案
Kaushik et al.
2020
Apremilast in orofacial granulomatosis—A report of five cases.
JP2021503448A5
(cg-RX-API-DMAC7.html )
2021-12-23
TW200306185A
(en )
2003-11-16
Combinations comprising EPOTHILONES and anti-metabolites
JPWO2021206167A5
(cg-RX-API-DMAC7.html )
2022-12-27
CN121218987A
(zh )
2025-12-26
雌激素受体降解剂和akt抑制剂的组合
JP2024518426A5
(cg-RX-API-DMAC7.html )
2025-05-01